NexGen ClinOps Consulting delivers over 20 years of global experience and expertise in clinical research. Director-level consulting for biopharma, biotech, and CROs. Leverage over 12 years of global clinical program and project management, service provider oversight and regulatory success to optimize your trials.
NexGen ClinOps Consulting offers hands-on expertise across every phase of clinical trial execution, from start-up to closeout — including targeted SWAT and Rescue support for studies in distress.
Clinical development planning and execution. Budget development, forecasting, tracking, and risk mitigation. Timeline management and milestone delivery.
End-to-end study lifecycle management (Phases I–IV, FIH, pediatric, vaccine trials). Day-to-day operational leadership and team coordination. Study design input and protocol review support.
Regulatory submission, planning and document review. Country/site feasibility, selection, and activation. Global launch support (NA & LATAM, EMEA, APAC, CEE, and Africa).
Monitoring · Data Flow · Service Providers, plans, documents and oversight. Monitoring and data flow oversight; query resolution support. Service providers alignment on monitoring strategy and reporting.
Protocol and Protocol Amendments development support. Safety oversight collaboration and clinical data review. Deviation tracking, and trending analysis for operational oversight and improvements.
Sponsor and site audit/inspection readiness; TMF management. SOP gap assessments; CAPA development & oversight. Continuous quality control & risk management.
From CRA to Director-level leadership — we bring deep operational insight across every phase of clinical trials. We bring expert-level leadership and full-lifecycle expertise across global clinical trials, from FIH to Phase IV.
We don’t just run the study — we align clinical operations with strategic goals, ensuring compliance, quality, and delivery. We align operational delivery with your program’s bigger picture — driving timelines, compliance, and trial success.
Struggling study? We specialize in rapid-response interventions for stalled or at-risk clinical trials. Our SWAT-style support rapidly identifies root causes and gets trials back on track.
Deep experience across cell therapy, oncology, gastroenterology, autoimmune disorders, cardiology, respiratory, endocrinology, vaccines, infectious diseases, and more — spanning global regions and emerging markets.
We adapt to your trial’s needs — whether you need full oversight, temporary fill-in, a specialized operations partner, or anything in between.
We act as your eyes and ears — ensuring CROs and service providers deliver on expectations with proactive communication, quality tracking, and accountability at every step.
Dr. Petro Savchenko is a Clinical Operations & Project Management Expert with over 20 years of Global Clinical Research Experience. As a medical doctor with deep clinical operational expertise, Petro helps biopharma and CRO clients execute complex Phase I–IV clinical trials.
He led clinical programs in Oncology & Immuno-Oncology (CAR-T, LBCL, FL, CD70, etc.), Gastroenterology (Crohn's, UC, IBD), Cardiology, Endocrinology, Rheumatology, Psychiatry, Neurology, Infectious Diseases, and more.
Proven outcomes from complex clinical programs around the world.

Client: Emerging Biotech, US-based
FIH study was delayed due to vendor misalignment and protocol deviation risks.

Client: Mid-size US Sponsor
Phase II oncology study across 7 countries was under-enrolling and facing frequent protocol amendments.

Client: Large Global Biopharma
Needed high-level operational oversight for a pivotal Phase III IBD trial in 30+ countries.
Clinical operations insights from NexGen ClinOps Consulting
Success is no longer about just reaching a goal — it's about predicting the obstacles on the journey. A resilient trial is built on data-informed site selection, flexible protocol design, and real-time predictive analytics.
Too many teams still treat RBQM as a regulatory checkbox. Real RBQM identifies critical-to-quality factors early, builds KRIs that trigger action, and embeds risk review into governance — changing decisions, not just dashboards.
You can have the best protocol, the strongest CRO, and the most innovative drug — but if sites aren't engaged, timelines slip and data suffers. Engaged sites mean faster enrollment, better retention, and higher quality data.
Looking for Director-level Clinical Operations expertise to support your clinical trial? Let’s discuss how NexGen ClinOps Consulting can help.